| scholarly article | Q13442814 |
| P2093 | author name string | Doina Ganea | |
| Weimin Kong | |||
| Jui-Hung Yen | |||
| Virginia Kocieda | |||
| P2860 | cites work | Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis | Q22241651 |
| No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies | Q24642539 | ||
| Structural basis for the activation of PPARgamma by oxidized fatty acids | Q27653525 | ||
| Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression | Q28199385 | ||
| Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation | Q28210028 | ||
| Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders | Q28279010 | ||
| Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques | Q28476681 | ||
| Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion | Q28509130 | ||
| Phospholipase A2 enzymes | Q28609770 | ||
| Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 | ||
| Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors | Q33230925 | ||
| Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms | Q33304942 | ||
| Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. | Q33619976 | ||
| Specialized pro-resolving lipid mediators in the inflammatory response: An update | Q33657562 | ||
| Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family | Q33683288 | ||
| In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells | Q33714400 | ||
| Emerging roles of PGE2 receptors in models of neurological disease | Q33756150 | ||
| Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival | Q33911514 | ||
| Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis | Q33982199 | ||
| Docosahexaenoic acid neurolipidomics | Q34002601 | ||
| Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model | Q34123859 | ||
| Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. | Q34140567 | ||
| Prostaglandin E2-dependent IL-23 production in aged murine dendritic cells | Q34208867 | ||
| A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. | Q34406066 | ||
| γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. | Q34434443 | ||
| The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering | Q34458562 | ||
| Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes | Q34522666 | ||
| CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain | Q34590006 | ||
| Docosahexaenoic Acid Suppresses Neuroinflammatory Responses and Induces Heme Oxygenase-1 Expression in BV-2 Microglia: Implications of Antidepressant Effects for Omega-3 Fatty Acids | Q34660464 | ||
| Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. | Q34661712 | ||
| Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation | Q34683399 | ||
| Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids | Q34800981 | ||
| Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury | Q34830891 | ||
| Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators | Q34993958 | ||
| Intestinal lamina propria dendritic cell subsets have different origin and functions. | Q35001346 | ||
| Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis | Q35817458 | ||
| Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis | Q35829642 | ||
| Developmental plasticity of CNS microglia | Q35940181 | ||
| Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases | Q35946021 | ||
| Origin and development of dendritic cells | Q37700819 | ||
| Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice | Q37704813 | ||
| The role of dendritic cells in CNS autoimmunity | Q37706120 | ||
| Lipoxins: regulators of resolution | Q37708528 | ||
| Microglia in neurodegenerative disease | Q37710380 | ||
| Essential fatty acids and human brain. | Q37717595 | ||
| Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease | Q37752020 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q37777431 | ||
| Targeting dendritic cells to treat multiple sclerosis. | Q37780678 | ||
| Inflammation in Neurological Disorders: A Help or a Hindrance? | Q37785417 | ||
| Development and homeostasis of dendritic cells | Q37790347 | ||
| Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern? | Q37798630 | ||
| Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid | Q39980648 | ||
| Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization | Q40049777 | ||
| Blood-derived dendritic cells in an acute brain injury. | Q40399923 | ||
| Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 | ||
| Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells | Q40548701 | ||
| Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. | Q40816506 | ||
| Brain dendritic cells in ischemic stroke: time course, activation state, and origin | Q41063596 | ||
| Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling | Q41330743 | ||
| Cyclooxygenases and the central nervous system | Q41646498 | ||
| Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. | Q41982686 | ||
| Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production | Q42079617 | ||
| Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis | Q42586722 | ||
| Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid | Q42911077 | ||
| Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells | Q43031080 | ||
| Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. | Q43142669 | ||
| Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats | Q43162767 | ||
| Docosahexaenoic acid modulates the expression of T-bet and GATA-3 transcription factors, independently of PPARalpha, through suppression of MAP kinase activation | Q43267873 | ||
| Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. | Q43291517 | ||
| Lipid mediator class switching during acute inflammation: signals in resolution. | Q43655799 | ||
| Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology | Q44047928 | ||
| Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. | Q44436559 | ||
| Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. | Q44533007 | ||
| Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. | Q44723213 | ||
| A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation | Q44788593 | ||
| Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery | Q44870537 | ||
| Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection | Q45166684 | ||
| Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation | Q45246494 | ||
| Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration. | Q45922075 | ||
| Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. | Q46011960 | ||
| PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia | Q46041470 | ||
| Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. | Q46202876 | ||
| Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia | Q46456075 | ||
| Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids | Q46479941 | ||
| Dendritic cell development from common myeloid progenitors. | Q46485177 | ||
| A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury | Q46977412 | ||
| Expression of CCR7 in multiple sclerosis: implications for CNS immunity | Q47661247 | ||
| The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. | Q48162247 | ||
| Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations | Q48250691 | ||
| CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions. | Q48328342 | ||
| Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain | Q48522641 | ||
| HLA-DR-positive dendritic cells of the normal human choroid plexus: a potential reservoir of HIV in the central nervous system | Q48554456 | ||
| Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. | Q48638381 | ||
| Temporal and spatial dynamics of cerebral immune cell accumulation in stroke | Q48715061 | ||
| The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system | Q48932592 | ||
| Two subsets of dendritic cells are present in human cerebrospinal fluid | Q48974990 | ||
| Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 | ||
| Brain dendritic cells and macrophages/microglia in central nervous system inflammation | Q49071798 | ||
| Distribution and fatty acid composition of phosphoglycerides in normal human brain. | Q49155643 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 | ||
| A Critical Role for Prostaglandin E2 in Podosome Dissolution and Induction of High-Speed Migration during Dendritic Cell Maturation | Q58620009 | ||
| Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis | Q73603837 | ||
| Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium | Q73608318 | ||
| Trial of celecoxib in amyotrophic lateral sclerosis | Q79794799 | ||
| Omega-3 polyunsaturated fatty acids affect lipopolysaccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38 | Q80328398 | ||
| The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis | Q80428039 | ||
| Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis | Q80707119 | ||
| Prostaglandin EP4 receptor agonist protects against acute neurotoxicity | Q81637831 | ||
| Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS | Q83020708 | ||
| Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat | Q83206221 | ||
| The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research | Q36048230 | ||
| Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis | Q36081667 | ||
| Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain | Q36345434 | ||
| PGE2-induced metalloproteinase-9 is essential for dendritic cell migration | Q36384618 | ||
| Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders | Q36463425 | ||
| CNS dendritic cells: critical participants in CNS inflammation? | Q36491057 | ||
| Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. | Q36506367 | ||
| Modulation of inflammation in brain: a matter of fat. | Q36719738 | ||
| IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. | Q36742236 | ||
| Insights into oxidative stress: the isoprostanes | Q36754565 | ||
| T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 | ||
| Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion | Q36948594 | ||
| A model for fatty acid transport into the brain. | Q36954182 | ||
| Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions | Q37018185 | ||
| Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia | Q37052586 | ||
| The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids | Q37077987 | ||
| The role of eicosanoids in the brain. | Q37093316 | ||
| Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids | Q37138726 | ||
| Inflammation on the mind: visualizing immunity in the central nervous system. | Q37184161 | ||
| The emerging role of docosahexaenoic acid in neuroinflammation. | Q37207182 | ||
| Therapeutic targets in prostaglandin E2 signaling for neurologic disease. | Q37221356 | ||
| Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation | Q37240246 | ||
| Altered lipid metabolism in brain injury and disorders | Q37254313 | ||
| Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor. | Q37258545 | ||
| Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia. | Q37269323 | ||
| Perivascular spaces and the two steps to neuroinflammation | Q37329042 | ||
| The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis | Q37397946 | ||
| Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis | Q37463199 | ||
| Prostanoids and inflammation: a new concept arising from receptor knockout mice | Q37554001 | ||
| Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders | Q37576857 | ||
| Eicosanoids and the endogenous control of acute inflammatory resolution | Q37660735 | ||
| Prostaglandin E2, an immunoactivator. | Q37668967 | ||
| Structures and mechanisms of enzymes in the leukotriene cascade | Q37680414 | ||
| P921 | main subject | dendritic cell | Q506253 |
| neuronitis | Q17157137 | ||
| P304 | page(s) | 277-291 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Clinical Lipidology | Q15758527 |
| P1476 | title | Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation | |
| P478 | volume | 6 |
| Q27023777 | Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis |
| Q38506789 | N-3 polyunsaturated fatty acids modulate B cell activity in pre-clinical models: Implications for the immune response to infections |
| Q34230865 | The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation |
Search more.